Effects of human I.V. immunoglobulin on bacterial clearance and granulocyte function in endotoxinaemia;Effekte von humanem i.v. Immunglobulin auf die Bakterien-Clearance und Granulozytenfunktion bei Endotoxinamie

Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie

Volumn 32, Issue 7, 1997, Pages 420-425

  Koch, Thea ^a,b   Heller, S ^a   Weber, K ^c   Heller, A ^a   Urbaschek, R ^a  

^a MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c NONE

Author keywords

bacterial clearance; endotoxinaemia; immunoglobulin; LPS clearance; PMN respiratory burst

Indexed keywords

IMMUNOGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG EFFICACY; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; GRANULOCYTE; HOST RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY INFECTION; LUNG INFECTION; MALE; NEUTROPHIL; NONHUMAN; RABBIT; RESPIRATORY BURST; SEPSIS;

EID: 0030874258     PISSN: 09392661     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-995083     Document Type: Article

References (25)

1. Nishijima MK, Takezawa J, Hososubo KK, Takahashi H, Shimada Y, Yoshiya I: Serial changes in cellular immunity of septic patients with multiple organ-system failure. Crit. Care Med. 1986;14:87-91
2. Koch T, Duncker HP, Axt R, Schiefer HG, van Ackern K, Neuhof H: Effects of hemorrhage, hypoxia, and intravascular coagulation on bacterial clearance and translocation. Crit. Care Med. 1993; 21:1758-1764
3. Koch T, Duncker HP, Axt R, Schiefer HG, van Ackern K, Neuhof H: Alterations of bacterial clearance induced by endotoxin and tumor necrosis factor. Infect. Immun. 1993;61:3143-3148
4. Calandra T, Glauser MP, Schellekens J, Verhoef J: Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial. J. Infect. Dis. 1988;158:312-319
5. Ziegler EJ, Fisher CJ, Sprung CL, et al. HA-1A Sepsis Study Group: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. N. Engl. J. Med. 1991;324:429-436
6. Greenman RL, Schein RMH, Martin MA, et al. XOMA Sepsis Study Group: A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. J. Amer. Med. Ass. 1991;266:1097-1102
7. McCuskey RS, Nishida J, McDonnell D, Baker GL, Urbaschek R, Urbaschek B: Effect of immunoglobulin G on the hepatic microvascular inflammatory response during sepsis. Shock 1996;5:28-33
8. Urbaschek R, Becker K-P, McCuskey RS, Urbaschek B: Influence of i.v. immunoglobulin on endotoxin-induced levels of endotoxin and of endotoxin-neutralizing-capacity. Shock 1995;5:193
9. Schedel I, Dreikhausen U, Nentwig B, Höckenschnieder M, Rauthmann D, Balikcioglu S, Coldewey R, Deicher H: Treatment of gram-negative septic shock with an immunoglobulin preparation: A prospective randomized clinical trial. Crit. Care Med. 1991;19:1104-1113
10. Dominioni L, Dionigi R, Zanello M, Chiaranda M, Dionigi R, Acquarolo A, Ballabio A, Sguotti C: Effects of high-dose IgG on survival of surgical patients with sepsis scores of 20 or greater. Arch. Surg. 1991;126:236-240
11. Pilz G, Kääb S, Neeser G, Class I, Schweigart U, Brähler A, Bujdoso O, Neumann R, Werdan K: Supplemental immunoglobulin (ivIgG) treatment in 163 patients with sepsis and septic shock - an observational study as a prerequisite for placebo-controlled clinical triais. Infection 1991;19:216-227
12. Glinz W, Grob PJ, Nydegger UE, Ricklin T, Stamm F, Stoffel D, Lasance A: Polyvalent immunoglobulins for prophylaxis of bacterial infection in patients following multiple trauma - a randomized, placebo-controlled study. Intensive Care Med. 1985;11:288-294
13. Pilz G, Kreuzer E, Kääb S, Appel R, Werdan K: Early sepsis treatment with immunogiobulins after cardiac surgery in score-identified high-risk patients. Chest 1994;105:76-82
14. Cafiero F, Gipponi M, Bonalumi U, Piccardo A, Sguotti C, Corbetta G: Prophylaxis of infection with intravenous immunoglobulins plus antibiotic for patients at risk for sepsis undergoing surgery for colorectal cancer; Results of a randomized, multicenter clinical trial. Surgery 1992;112:24-31
15. Cometta A, Baumgartner J-D, Lee ML, Hanique G, Glauser MP, the intravenous immunoglobulin collaborative study group: Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection. N. Engl. J. Med. 1992;327:234-240
16. Sandys GH: A new method for preventing swarming of Proteus sp. with a description of a new medium suitable for use in routine laboratory practice. J. Med. Lab. Technol. 1960;17:224-233
17. Ditter B, Becker K-P, Urbaschek R, Urbaschek B: Quantitativer Endotoxinnachweis. Automatisierter, kinetischer Limulus-Amöbozyten-Lysat-Mikrotiter-Test mit Messung probenabhängiger Interferenzen. Drug Res. 1983;33:681-687
18. Urbaschek R, Becker K-P: Endotoxinnachweis im Plasma. Spezifität und Aussagekraft für Entwicklung und Prognose einer Sepsis. Infusionsther. Transfusionsmed. 1993;1:16-20
19. Emmendörfer A, Hecht M, Lohmann-Matthes M-L, Roesler J: A fast and easy method to determine the production of reactive intermediates by human and murine phagocytes using dihydrorhodamine 123. J. Immunol. Methods 1990;131:269-275
20. Nazzari C, Gaeta A, Lun MT, Raponi G, Antonelli M, Mancini C, Filadoro F: Effect of intravenous immunoglobulin on opsonic activity and TNF production in patients at high risk for sepsis syndrome. Microbiologica 1993;16:251-258
21. Shimozato T, Iwata M, Tamura N: Suppression of tumor necrosis factor alpha production by a human immunoglobulin preparation for intravenous use. Infect. Immunol. 1990;58:1384-1390
22. Andersson UG, Björk L, Skansen-Saphir U, Andersson JP: Down regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG. Immunology 1993;79:211-216
23. Darville T, Tabor T, Simpson K, Jacobs RF: Intravenous immunoglobulin modulates human mononuclear phagocyte tumor necrosis factor-α production in vitro. Pediatr. Res. 1994;35:397-403
24. Wagner DR, Heinrich D: Influence of polyclonal immunoglobulins on the polymorphonuclear leukocyte response to lipopolysaccharide of Salmonella enteritides as measured with luminol-enhanced chemiluminescence. Infect. Immun. 1994;62:4320-4324
25. Pfeiffer L, Ehrhardt N, Kretzschmar M, Urbaschek R, Schubert K, Schirrmeister W: Endotoxinämie und Multiorganversagen nach Polytrauma. Anaesthesiol. Reanimat. 1996;21:91-96